Diamyd Medical AB (publ)
DYMDF
$0.73
$0.000.00%
OTC PK
| 02/28/2026 | 11/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -57.53% | 1,263.16% | |||
| Total Other Revenue | -- | 0.00% | |||
| Total Revenue | -57.69% | 1,200.00% | |||
| Cost of Revenue | -12.37% | 32.53% | |||
| Gross Profit | -3.68% | -0.55% | |||
| SG&A Expenses | 13.80% | 20.88% | |||
| Depreciation & Amortization | 4.61% | 3.00% | |||
| Other Operating Expenses | 5.00% | -75.00% | |||
| Total Operating Expenses | 38.77% | 7.02% | |||
| Operating Income | -39.25% | -6.53% | |||
| Income Before Tax | -34.64% | -10.45% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -34.64% | -10.45% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -34.64% | -10.45% | |||
| EBIT | -39.25% | -6.53% | |||
| EBITDA | -40.57% | -6.40% | |||
| EPS Basic | -34.84% | -10.26% | |||
| Normalized Basic EPS | -36.64% | -8.92% | |||
| EPS Diluted | -34.84% | -10.26% | |||
| Normalized Diluted EPS | -36.64% | -8.92% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||